To investigate whether TFAM expression is associated with tumor progression in NSCLC, western blot analysis was performed on samples from 30 NSCLC patients (each sample including tumor tissue and matched adjacent normal tissue from the same patient). Here, TFAM is linked to non-small cell lung carcinoma.